Xi Cao

机构：Beijing Tongren Hospital · ORCID：0000-0001-5447-6766

发表论文 88 篇 · 总被引 2653 次 · h-index 31

代表论文

• Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer (2024 · Journal of Controlled Release · 被引 42)
• Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis (2022 · Drug Delivery · 被引 42)
• Bifidobacterium pseudolongum ‐Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP‐PKG‐mTORC1 Pathway (2024 · Advanced Science · 被引 41)
• Berberine Metabolites Stimulate GLP-1 Secretion by Alleviating Oxidative Stress and Mitochondrial Dysfunction (2024 · The American Journal of Chinese Medicine · 被引 24)
• TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis (2024 · Frontiers in Molecular Biosciences · 被引 19)
• Integrated analysis of gut microbiome and its metabolites in ACE2-knockout and ACE2-overexpressed mice (2024 · Frontiers in Cellular and Infection Microbiology · 被引 14)